CPT1A and ovarian serous adenocarcinoma: Huang et al. indicated that CPT1A played a vital role in platinum resistance occurrence in high-grade serous ovarian cancer via RNA-seq, whole-genome sequencing and proteomic profiling comprehensive and reproducible analyses of intra-patient cell line pairs derived from three HGSOC patients before and after acquiring platinum resistance, extending prior work showing that a reduced CPT1A expression is associated with platinum sensitivity in a collagen type XI alpha 1 (COL11A1)-dependent in vitro model of platinum resistance [29,60,61].